Eating Disorders in Patients With Phenylketonuria
- Sponsor
- Central Hospital, Nancy, France
- Study ID
- NCT07698743
- Status
- Recruiting
Conditions
Eligibility Criteria
- Sex
- ALL
- Age
- N/A - N/A
- Healthy Volunteers
- Not accepted
Study Details
The prevalence of eating disorders and BMI are significantly higher in PKU patients than in the general population. The protein-restricted diet associated with high carbohydrate intake and the severity of the genetic defect and disease can lead to weight gain in these patients; However, the link between restrictive diets, EDs, and obesity has not been demonstrated in patients with PKU. These issues remain poorly explored, meaning that patients may not be detected and treated.
Key Dates
- First listed
- Jul 13, 2026
- Start date
- Dec 4, 2025
- Status verified
- Jul 2026
- Primary completion
- Jan 1, 2028
- Completion
- Apr 2, 2028
Study Design
- Enrollment
- 70 participants (estimated)
Primary Outcome Measure
Phenotypes related to TCA in the PCU cohort of the Reference Center for Hereditary Metabolic Diseases [ Time Frame: from january 2026 to january 2028 ]
Central Contacts
- Eva Feigerlova, MD PhD MMEd+330383154796
Related Studies
- Educational, Social Support, and Nutritional Interventions and Their Cumulative Effect on Pregnancy Outcomes and Quality of Life in Teen and Adult Women With PhenylketonuriaRecruiting · Emory University · Atlanta, Georgia
- Long-Term Follow Up Study of Subjects Previously Administered HMI 102Enrolling By Invitation · Homology Medicines, Inc · Boston, Massachusetts
- A Study of Sepiapterin in Participants With Phenylketonuria (PKU)PHASE3 · Recruiting · PTC Therapeutics · Indianapolis, Indiana
- A Study of JNT-517 in Participants With Phenylketonuria (PKU)PHASE3 · Recruiting · Otsuka Pharmaceutical Development & Commercialization, Inc. · Los Angeles, California